Description

N,n-Dimethyl-4-Oxo-3,4-Dihydroquinazoline-7-Carboxamide is a high-purity, advanced pharmaceutical intermediate belonging to the quinazolinone class of heterocyclic compounds. This compound is valued for its role as a critical building block in the synthesis of novel, biologically active molecules, particularly in medicinal chemistry research and development. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, such as kinase inhibitors and other targeted small-molecule drugs.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug candidates, especially kinase inhibitors.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Used in multi-step organic synthesis to construct complex molecules with potential biological activity.
• Biochemical Tool Compound: May be utilized in biochemical assays to study enzyme function and cellular pathways.
• Academic Research: Employed in university and institutional labs for heterocyclic chemistry studies and novel compound library generation.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Product Name	N,n-Dimethyl-4-Oxo-3,4-Dihydroquinazoline-7-Carboxamide
CAS No.	1092460-54-2
Molecular Formula	C₁₁H₁₁N₃O₂
Molecular Weight	217.23 g/mol
Synonyms	7-Carbamoyl-N,N-dimethyl-4-oxo-3,4-dihydroquinazoline; 7-(Dimethylcarbamoyl)-4-oxo-3,4-dihydroquinazoline; N,N-Dimethyl-4-oxo-3,4-dihydroquinazoline-7-carboxamide; 3,4-Dihydro-4-oxo-N,N-dimethylquinazoline-7-carboxamide; Quinazoline-7-carboxamide, 3,4-dihydro-N,N-dimethyl-4-oxo-; 1092460-54-2
EINECS	Contact for details

Quality Control

Our N,n-Dimethyl-4-Oxo-3,4-Dihydroquinazoline-7-Carboxamide is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. We provide a detailed Certificate of Analysis (COA) with each shipment, ensuring traceability and compliance with your research or cGMP-grade requirements. Specifications are designed to meet the stringent needs of pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.